Global Congress on
Nephrology and Kidney Health
May 20–21, 2027 | Paris, France
30+ Years of Management Experience
Paris, France
Phone: +44 2045874848
WhatsApp: +44 7429481517

Nephrology Congress 2027

Home › Scientific Program
Yohko Nagai
Yohko Nagai

Tokyo Kidney Research Institute, Japan

Title : The morphological vascular wall changes of renal arteries and arterioles in normotensive and hypertensive patients

Abstract:

The deterioration of the renal function is one of the prominent risks in human health. Nephrologists mainly focused on the glomerular changes for the genesis of kidney failure. The glomerular hypertension, because of the glomerular hyperfiltration, was considered to be the most affected by glomerular blood flow, however; a decrease in blood flow is also harmful inducing the glomerular ischemia. The blood flow from the main renal arteries flows through many different vessels into the afferent arterioles; this directly manages the blood flow and the pressure to glomeruli, playing a very important role. We found extremely proliferative smooth muscle cell changes and narrowing of its lumens in the afferent arterioles, by the long-term treatment with Renin-Angiotensin-Aldosterone blockers (ARBs, ACEIs); experimented using several strains of rats. We also found the same findings in human afferent arterioles studied using the healthy parts of the removed kidneys due to malignancy. Hypertensive patients showed more narrowed lumens of the arcuate arteries with elastosis/elastofibrosis than normotensive patients with or without RAS inhibitors treatment. Patient with severe narrowing in their arcuate arteries, also showed narrowed arteriolar lumens sometimes accompanied with hyaline deposition; although in some cases there was no probable relation to systemic blood pressure level. We should still consider aging too. Nowadays, the kinds of medicine which have antihypertensive effects we can use, are strikingly increasing. It is important to study more about mineral corticoid receptor blocker, synthetase inhibitor, ARNI, SGLT2 inhibitor, and their hemodynamic and the morphological effect on renal vessels.

Biography:

Yohko Nagai, M.D., Ph.D. graduated from the University of Niigata, Japan in 1977. She obtained a Ph.D. degree in 1983 in the Department of Kidney center. She studied in the Department of Pathology, Toho University from 1987 to 1991, looking at the morphology of renal small arteries and arterioles. She worked as a clinician in the Department of General Medicine and Emergency Care, Toho University until 2022 continuing her research as a member of the Tokyo Kidney Research Institute, which is a division of Research Organization for Kidney Vasculitis and Aging.